Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 27, 2020	Sep. 27, 2019
Current assets:
Cash and cash equivalents	$ 724,931	$ 797,210
Restricted cash	9,513	8,383
Short-term investments	174,859	119,146
Accounts receivable, net of allowance for doubtful accounts of $11,262 and $9,775	247,043	189,115
Contract assets	223,739	195,651
Inventories, net	28,331	32,331
Prepaid expenses and other current assets	51,156	39,704
Total current assets	1,459,572	1,381,540
Long-term investments	127,294	179,587
Property, plant, and equipment, net	551,027	537,432
Operating lease right-of-use assets	79,439	0
Intangible assets, net	167,917	180,891
Goodwill	332,979	334,829
Other non-current assets	97,353	93,395
Deferred taxes	129,252	114,075
Total assets	2,944,833	2,821,749
Current liabilities:
Accounts payable	9,041	15,212
Accrued liabilities	245,869	268,144
Income taxes payable	15,186	3,506
Contract liabilities	19,745	19,991
Operating lease liabilities	17,413	0
Total current liabilities	307,254	306,853
Non-current contract liabilities	25,074	24,404
Non-current operating lease liabilities	64,423	0
Other non-current liabilities	178,805	177,462
Total liabilities	575,556	508,719
Stockholders’ equity:
Retained earnings	2,395,575	2,327,877
Accumulated other comprehensive (loss)	(31,615)	(20,625)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,364,059	2,307,351
Controlling interest	5,218	5,679
Total stockholders’ equity	2,369,277	2,313,030
Total liabilities and stockholders’ equity	2,944,833	2,821,749
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 64,422,131 shares issued and outstanding at March 27, 2020 and 63,911,270 at September 27, 2019
Stockholders’ equity:
Common stock	58	58
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,224,820 shares issued and outstanding at March 27, 2020 and 36,229,820 at September 27, 2019
Stockholders’ equity:
Common stock	$ 41	$ 41